Co-Diagnostics (HAM:C970) Net Interest Margin (Bank Only) %


HAM:C970 Co-Diagnostics Inc HAM:C970
60 GF Score
Price €5.55
GF Value €3.88
! 6 Warning Signs
View Full Analysis

What is Co-Diagnostics Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HAM:C970
60GF Score
Co-Diagnostics Inc HAM:C970
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Co-Diagnostics (HAM:C970) Overvalued in 2026?

Based on GuruFocus' analysis, Co-Diagnostics stock appears to be overvalued. The current stock price of €5.55 is trading 43% above its estimated GF Value™ of €3.88.

Key valuation signals for HAM:C970:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €3.88 vs. price of €5.55 (43% above fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the HAM:C970 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Co-Diagnostics Business Description

Other Exchanges CODX:USA0A50:UK
Address 2401 S. Foothill Drive, Suite D, Salt Lake City, UT, USA, 84109
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
60GF Score

Get the complete analysis for HAM:C970

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.55
Price
€3.88
GF Value